Rare CC genotype of XPD/ERCC2 gene, may be considered as an unfavorable predictive factor for chemotherapy based on cisplatin and gemcitabine in patients with advanced NSCLC. The gene discussed is ERCC2; the disease is non-small cell lung carcinoma.